Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)

Date : 11/18/2019 @ 12:29PM
Source : Edgar (US Regulatory)
Stock : Phio Pharmaceuticals Corporation (PHIO)
Quote : 9.64  -0.13 (-1.33%) @ 11:34PM
Phio Pharmaceuticals share price Chart
After Hours
Last Trade
Last $ 9.70 ▲ 0.06 (0.62%)

Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)

Filed Pursuant to Rule 424(b)(3)

Registration Nos. 333-227173 and 333-227617

 

 

 

Phio Pharmaceuticals Corp.

 

PROSPECTUS SUPPLEMENT No. 1

To Prospectus Dated October 1, 2018

 

 

This Prospectus Supplement No. 1 supplements and amends the prospectus dated October 1, 2018, covering the registration of 3,725,714 units (each unit consisting of one share of common stock and one warrant to purchase one share of our common stock), 17,702,858 pre-funded units (each pre-funded unit consisting of one pre-funded warrant to purchase one share of common stock and one warrant to purchase one share of common stock), 17,702,858 shares of common stock underlying the pre-funded warrants and 21,428,572 shares of common stock underlying the warrants (the “Warrants”).

 

On November 17, 2019, we unilaterally reduced the per share exercise price of all of the outstanding Warrants issued under this prospectus to $0.19 per share, which was equal to the closing price of our common stock on the Nasdaq Capital Market on November 15, 2019. The reduction will be effective as of November 19, 2019, concurrent with the closing of an equity offering of our common stock. Other than the reduction in the per share exercise price, all other terms and provisions of the Warrants remains unchanged. Upon the exercise of the Warrants, we would potentially receive proceeds of up to $4.07 million. There can be no assurance that the Warrants will be exercised.

 

You should read this prospectus supplement, together with additional information described under the headings “Incorporation of Certain Information by Reference” and “Where You Can Find More Information” in the prospectus dated October 1, 2018 carefully before you invest in our securities.

 

Investing in our securities involves a high degree of risk. Before making any investment in these securities, you should consider carefully the risks and uncertainties described in the section entitled “Risk Factors” beginning on page 4 of the prospectus dated October 1, 2018.

 

 

The date of this prospectus supplement is November 18, 2019

Phio Pharmaceuticals (NASDAQ:PHIO)
Historical Stock Chart

1 Year : From Jan 2019 to Jan 2020

Click Here for more Phio Pharmaceuticals Charts.

Phio Pharmaceuticals (NASDAQ:PHIO)
Intraday Stock Chart

Today : Thursday 23 January 2020

Click Here for more Phio Pharmaceuticals Charts.

Latest PHIO Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:us D:20200123 23:57:12